FDA PMA FDA Class 3 Approved 🇺🇸 United States

System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

PMA: P970008 · Supplement: S048 · Decision Apr 30, 2010
Classifications
1
FEI Numbers
10
Registration Numbers
10

Basic Information

Device Name
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
Trade Name
UROLOGIX TARGIS SYSTEM
PMA Number
P970008
Supplement Number
S048
Device Class
FDA Class 3
Product Code
MEQ
Generic Name
System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy
Medical Specialty
Unknown
Advisory Committee
Gastroenterology, Urology
Decision
Approved
Decision Code
APPR
Decision Date
April 30, 2010
Date Received
March 3, 2010
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR SOFTWARE CHANGES TO THE UROLOGIX TARGIS SYSTEM COOLWAVE CONTROL UNIT MODEL 5000A.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MEQ System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy